A Study Evaluating TRIV-509 in Atopic Dermatitis

NCT07167758 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

95

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: TRIV-509
DRUG: Placebo

Sponsor

Triveni Bio